HDAC4/HDAC5/HDAC9 (pSer246), (pSer259), (pSer220) antibody

Details for Product No. ABIN319279
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Antigen
Epitope
pSer220, pSer246, pSer259
(7), (7), (7), (3), (3), (2), (1)
Reactivity
Human, Mouse (Murine)
(10), (5)
Host
Rabbit
(10)
Clonality
Polyclonal
Application
Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Western Blotting (WB)
(10), (7), (5), (4), (1)
Pubmed 4 references available
Quantity 0.1 mL
Shipping to United States ( )
Availability Will be delivered in 6 to 8 Business Days
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Immunogen The antiserum was produced against synthesized phosphopeptide derived from human HDAC4/HDAC5/HDAC9 around the phosphorylation site of Serine 246/259/220 (T-A-SP-EP).
Purification Immunoaffinity Chromatography: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide was removed by chromatography using non-phosphopeptide corresponding to the phosphorylation site.
Background Synonyms: HDAC-4, HDAC-5, HDAC-9, Histone Deacetylase
Application Notes Western Blot (1/500-1/1000). Immunohistochemistry (1/50-1/100).
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.
Restrictions For Research Use only
Buffer PBS (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % Sodium Azide and 50 % Glycerol.
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handling Advice Avoid repeated freezing and thawing.
Storage -20 °C
Storage Comment Store the antibody (in aliquots) at-20 °C.
Supplier Images
anti-HDAC4/HDAC5/HDAC9 (pSer246), (pSer259), (pSer220) antibody anti-HDAC4/HDAC5/HDAC9 (pSer246), (pSer259), (pSer220) antibody
anti-HDAC4/HDAC5/HDAC9 (pSer246), (pSer259), (pSer220) antibody (2) anti-HDAC4/HDAC5/HDAC9 (pSer246), (pSer259), (pSer220) antibody (Image 2)
Background publications Vigushin, Coombes: "Targeted histone deacetylase inhibition for cancer therapy." in: Current cancer drug targets, Vol. 4, Issue 2, pp. 205-18, 2004 (PubMed).

Thiagalingam, Cheng, Lee et al.: "Histone deacetylases: unique players in shaping the epigenetic histone code." in: Annals of the New York Academy of Sciences, Vol. 983, pp. 84-100, 2003 (PubMed).

Marmorstein: "Structure and function of histone acetyltransferases." in: Cellular and molecular life sciences : CMLS, Vol. 58, Issue 5-6, pp. 693-703, 2001 (PubMed).

Cress, Seto: "Histone deacetylases, transcriptional control, and cancer." in: Journal of cellular physiology, Vol. 184, Issue 1, pp. 1-16, 2000 (PubMed).

Validation Images
Catalog No. ABIN319279
357.50 $
Plus shipping costs $45.00
Quantity
Price
0.1 mL
357.50 $

Order hotline:

  • +1 877 302 8632
  • +1 888 205 9894 (TF)
Did you look for something else?